Formerly Tata India Pharma & Healthcare Reg DP
₹ 24.7805
NAV (Mar 27)
Sectoral / thematic - pharma and healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).
The pharma benchmark index itself has been a material underperformer over an extended time frame.
Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.
Scripbox does not recommend investing in the dividend option of a fund because dividends are taxable at a higher rate than withdrawals.
Investment Duration5 years
0
Total Investment0
Wealth Gained0
Total Corpus Created (₹)
With CAGR of 11.25 % in 5 years₹ 24.7805
NAV (Mar 27)
Last 1Y | 57.8% |
Last 3Y | 20% |
Last 5Y | 22.9% |
Last 10Y | NA |
Since Inception | 11.6% |
6 Month CAGR | 24% |
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However,there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
Expense Ratio | 2.26 |
Launched (9y ago) | Dec 28, 2015 |
AUM in Crores | 872.210 |
ISIN | INF277K017A7 |
Lock-in | No Lock-in |
Benchmark | Nifty Pharma TR INR |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | 14.8 |
Standard Deviation (5yr) | 17.1 |
Beta (3yr) | 0.89 |
Beta (5yr) | 0.75 |
Sharpe Ratio (3yr) | 0.99 |
Sharpe Ratio (5yr) | 1.047 |
YTM | 0 |
of
for
with step up of
Asset | Returns | Total Corpus | Gains | CAGR |
---|---|---|---|---|
Tata India Pharma & Healthcare Fund of (PIDCW-A) | 13,17,475 | 5,84,863 | 22.9% | |
EPF | 9,00,761 | 1,68,149 | 8.50% | |
Property | 8,67,662 | 1,35,050 | 7.00% | |
PPF | 8,69,819 | 1,37,207 | 7.10% | |
Bank FD | 8,46,471 | 1,13,859 | 6.00% | |
Gold | 8,46,471 | 1,13,859 | 6.00% | |
Savings Bank | 8,25,950 | 93,338 | 5.00% |
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
sun pharmaceuticals industries ltd
14.3%lupin ltd
10.1%aurobindo pharma ltd
8.4%cipla ltd
7%dr reddy's laboratories ltd
5.3%healthcare
94.1%basic materials
1.8%Fund Name | Fund Size | Outperformance Consistency |
---|---|---|
₹ 14,147 cr | ||
₹ 16,756 cr | ||
₹ 21,301 cr | ||
₹ 12,185 cr | ||
₹ 9,977 cr |
Tata Asset Management Limited
Fund Name | Scripbox Opinion | Till Date CAGR | |
---|---|---|---|
12.7% | 12.8% | ||
19.8% | 17.6% | ||
17.4% | 16.3% | ||
32.2% | 15.6% | ||
19.8% | 17.6% |
Tata India Pharma & Healthcare Fund of (PIDCW-A) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 11.6% over a period of 8 years. The fund was previously known as Tata India Pharma & Healthcare Reg DP. The fund is managed by Tata Asset Management Limited. The fund manager’s name is Meeta Shetty.
Nav of Tata India Pharma & Healthcare Fund of (PIDCW-A) as of 3/27/2024 is ₹24.78 with the total AUM as of 3/28/2024 is ₹872.21. With Scripbox you can compare and check the latest nav for all mutual funds in India. Tata India Pharma & Healthcare Fund of (PIDCW-A) was launched on Dec 28, 2015. The category risk of the fund is Very High Risk.
The minimum SIP amount for Tata India Pharma & Healthcare Fund of (PIDCW-A) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
Tata India Pharma & Healthcare Fund of (PIDCW-A) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to Nifty Pharma TR INR.
Tata India Pharma & Healthcare Fund of (PIDCW-A) is rated as a 1 fund in Equity and delivered 57.8% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Tata India Pharma & Healthcare Fund of (PIDCW-A).
What is Tata India Pharma & Healthcare Fund of (PIDCW-A)?
How to invest in Tata India Pharma & Healthcare Fund of (PIDCW-A)?
You can invest in Tata India Pharma & Healthcare Fund of (PIDCW-A) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?
What is the minimum sip amount of Tata India Pharma & Healthcare Fund of (PIDCW-A)?
The minimum sip amount for Tata India Pharma & Healthcare Fund of (PIDCW-A) is ₹1000. You can invest in multiples of ₹5000.
Is Tata India Pharma & Healthcare Fund of (PIDCW-A) good to invest in?
As per Scripbox experts, Tata India Pharma & Healthcare Fund of (PIDCW-A) is a Not Recommended fund. You can investTata India Pharma & Healthcare Fund of (PIDCW-A) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.
What is the expense ratio of the Tata India Pharma & Healthcare Fund of (PIDCW-A)?
The expense ratio of the Tata India Pharma & Healthcare Fund of (PIDCW-A) is 2.26% for regular plan.